STOCK TITAN

[144] Vera Therapeutics, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Reporting notification to sell 2,900 common shares. The Form 144 filing lists 2,900 shares of common stock proposed for sale through Morgan Stanley Smith Barney LLC with dates 02/20/2026 and 02/23/2026.

The filing describes the shares as restricted stock vesting under a registered plan and identifies the transaction as an issuer‑related sale; cash‑flow treatment and sale timing are not detailed in the excerpt.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for VERA disclose?

The Form 144 discloses a proposed sale of 2,900 common shares through Morgan Stanley Smith Barney LLC with filing dates 02/20/2026 and 02/23/2026. The shares are described as restricted stock vesting under a registered plan.

Who is the broker handling the sale in the VERA Form 144?

The broker listed is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY. The filing ties the proposed sale of 2,900 shares to that broker in the provided excerpt.

How many shares does VERA propose to sell under this Form 144?

The filing shows a proposed sale amount of 2,900 common shares. The document labels these shares as restricted stock vesting under a registered plan and lists the relevant dates as 02/20/2026 and 02/23/2026.

Are the shares in the VERA filing restricted or freely tradable?

The shares are described in the excerpt as restricted stock vesting under a registered plan. That wording indicates they originated as restricted shares that vested under a plan; the filing itself reflects a proposed resale notification rather than waiver language.

Does the Form 144 excerpt state proceeds or sale timing for VERA shares?

The excerpt lists dates and the number of shares (2,900) but does not state sale proceeds or precise execution timing. The filing identifies the broker and the nature of the shares; price and final settlement details are not shown in the provided text.
Vera Therapeutics, Inc.

NASDAQ:VERA

VERA Rankings

VERA Latest News

VERA Latest SEC Filings

VERA Stock Data

2.99B
69.16M
Biotechnology
Pharmaceutical Preparations
Link
United States
BRISBANE